Literature DB >> 29980825

Echocardiographic Follow-Up of Congenital Aortic Valvular Stenosis II.

Ayşe Güler Eroğlu1, Sezen Ugan Atik2, Betül Çinar3, Murat Tuğberk Bakar4, İrfan Levent Saltik1.   

Abstract

We evaluated the natural course of congenital aortic valvular stenosis (AVS) and factors affecting AVS progression during long-term follow-up with echocardiography. Medical records of 388 patients with AVS were reviewed; patients with concomitant lesions other than aortic regurgitation (AR) were excluded. Trivial AVS was defined as a transvalvular Doppler peak systolic instantaneous gradient of < 25 mmHg; mild stenosis, 25-49 mmHg; moderate stenosis, 50-75 mmHg; and severe stenosis, > 75 mmHg. Median age of the patients was 3 years (range 0 day to 21 years), and 287 (74%) were male. A total of 355 patients were followed with medical treatment alone for a median of 4.6 years (range 1 month to 20.6 years), and the degree of AVS increased in 75 (21%) patients. The risk of AVS progression was higher when AVS was diagnosed in neonates (OR 4.29, CI 1.81-10.18, p = 0.001) and infants (OR 3.79, CI 2.21-6.49, p = 0.001). After the infancy period, bicuspid valve morphology increased AVS progression risk (OR 2.4, CI 1.2-4.6, p = 0.034). Patients with moderate AVS were more likely to have AVS progression (OR 2.59, CI 1.3-5.1, p = 0.006). Bicuspid valve morphology increased risk of AR development/progression (OR 1.77, CI 1.1-2.7, p = 0.017). The patients with mild and moderate AVS were more likely to have AR development/progression (p = 0.001). The risk of AR development/progression was higher in patients with AVS progression (OR 2.25, CI 1.33-3.81, p = 0.002). Newborn babies and infants should be followed more frequently than older patients according to disease severity. Bicuspid aortic valve morphology and moderate stenosis are risk factors for the progression of AVS and AR.

Entities:  

Keywords:  Aortic regurgitation; Aortic valvular stenosis; Bicuspid aortic valve; Echocardiography

Mesh:

Year:  2018        PMID: 29980825     DOI: 10.1007/s00246-018-1928-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  21 in total

1.  Accuracy of the Doppler-derived pressure gradient in pediatric patients with aortic valvular stenosis: is the correction for pressure recovery necessary?

Authors:  Hirokuni Yamazawa
Journal:  Hokkaido Igaku Zasshi       Date:  2010-07

2.  Aortic stenosis: the spectrum of practice.

Authors:  O Khalid; D M Luxenberg; C Sable; O Benavidez; T Geva; B Hanna; R Abdulla
Journal:  Pediatr Cardiol       Date:  2006-11-16       Impact factor: 1.655

3.  What is the validity of continuous wave Doppler grading of aortic regurgitation severity? A chronic animal model study.

Authors:  M Ishii; M Jones; T Shiota; I Yamada; R S Heinrich; S R Holcomb; T el-Kadi; A P Yoganathan; D J Sahn
Journal:  J Am Soc Echocardiogr       Date:  1998-04       Impact factor: 5.251

4.  ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography.

Authors:  M D Cheitlin; J S Alpert; W F Armstrong; G P Aurigemma; G A Beller; F Z Bierman; T W Davidson; J L Davis; P S Douglas; L D Gillam
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

Review 5.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  Circulation       Date:  2017-03-15       Impact factor: 29.690

6.  Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study.

Authors:  M Samánek; M Vorísková
Journal:  Pediatr Cardiol       Date:  1999 Nov-Dec       Impact factor: 1.655

7.  The influence of valve physiology on outcome following aortic valvotomy for congenital bicuspid valve in children: 30-year results from a single institution.

Authors:  Tara Karamlou; Irving Shen; Bahaaldin Alsoufia; Grant Burch; Mark Reller; Michael Silberbach; Ross M Ungerleider
Journal:  Eur J Cardiothorac Surg       Date:  2005-01       Impact factor: 4.191

8.  Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Authors:  R O Bonow; B Carabello; A C de Leon; L H Edmunds; B J Fedderly; M D Freed; W H Gaasch; C R McKay; R A Nishimura; P T O'Gara; R A O'Rourke; S H Rahimtoola; J L Ritchie; M D Cheitlin; K A Eagle; T J Gardner; A Garson; R J Gibbons; R O Russell; T J Ryan; S C Smith
Journal:  Circulation       Date:  1998-11-03       Impact factor: 29.690

9.  Doppler evaluation of aortic valve area in children with aortic stenosis.

Authors:  A R Bengur; A R Snider; J N Meliones; R P Vermilion
Journal:  J Am Coll Cardiol       Date:  1991-11-15       Impact factor: 24.094

10.  Second natural history study of congenital heart defects. Aortic stenosis: echocardiography.

Authors:  R A Nishimura; D R Pieroni; F Z Bierman; S D Colan; S Kaufman; S P Sanders; J B Seward; A J Tajik; J W Wiggins; K G Zahka
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

View more
  2 in total

1.  Physical models of infant mortality: implications for defects in biological systems.

Authors:  Alex Bois; Eduardo M García-Roger; Elim Hong; Stefan Hutzler; Ali Irannezhad; Abdelkrim Mannioui; Peter Richmond; Bertrand M Roehner; Stéphane Tronche
Journal:  J Biol Phys       Date:  2020-11-25       Impact factor: 1.365

2.  Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease.

Authors:  Christina V Theodoris; Ping Zhou; Lei Liu; Yu Zhang; Tomohiro Nishino; Yu Huang; Aleksandra Kostina; Sanjeev S Ranade; Casey A Gifford; Vladimir Uspenskiy; Anna Malashicheva; Sheng Ding; Deepak Srivastava
Journal:  Science       Date:  2020-12-10       Impact factor: 47.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.